| P2093 | author name string | Kenshi Hayashi | |
| | Takashi Fujita | |
| | Masakazu Yamagishi | |
| | Tetsuo Konno | |
| | Masa-Aki Kawashiri | |
| | Akihiko Hodatsu | |
| | Akira Funada | |
| | Noboru Fujino | |
| | Yoji Nagata | |
| P2860 | cites work | A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart | Q24294587 |
| | A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia | Q24645034 |
| | A method and server for predicting damaging missense mutations | Q27860835 |
| | A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients | Q28182167 |
| | Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy | Q28198707 |
| | Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy | Q28236892 |
| | Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction | Q28237729 |
| | Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes | Q28248327 |
| | Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency | Q28250719 |
| | A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy | Q28253215 |
| | Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese | Q28279418 |
| | Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish | Q30481232 |
| | Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults | Q34058337 |
| | Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy | Q34062582 |
| | Hypertrophic cardiomyopathy: a systematic review | Q34117625 |
| | Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy | Q34120159 |
| | The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events | Q34145917 |
| | Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy | Q34474908 |
| | Inactivation of Myosin binding protein C homolog in zebrafish as a model for human cardiac hypertrophy and diastolic dysfunction | Q37328713 |
| | A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations | Q38106918 |
| | Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects | Q38125941 |
| | The rapid detection of unknown mutations in nucleic acids. | Q40786087 |
| | Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy | Q41511752 |
| | An in vivo cardiac assay to determine the functional consequences of putative long QT syndrome mutations. | Q41930866 |
| | Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling | Q43073464 |
| | Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy | Q47879338 |
| | Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations | Q48031222 |
| | Antihypertensive therapy in hypertrophic cardiomyopathy. | Q51836542 |
| | A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death. | Q54641381 |
| | Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. | Q54706020 |
| | 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the Ameri | Q55055185 |
| | Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations | Q57841015 |
| | Homozygotes for a R869G Mutation in the β -myosin Heavy Chain Gene have a Severe Form of Familial Hypertrophic Cardiomyopathy | Q57907353 |
| P433 | issue | 11 | |
| P921 | main subject | Danio rerio | Q169444 |
| | hypertrophic cardiomyopathy | Q1364270 |
| | heterozygosity | Q124059385 |
| P304 | page(s) | H1594-604 | |
| P577 | publication date | 2014-10-03 | |
| P1433 | published in | American Journal of Physiology Heart and Circulatory Physiology | Q3193662 |
| P1476 | title | Compound heterozygosity deteriorates phenotypes of hypertrophic cardiomyopathy with founder MYBPC3 mutation: evidence from patients and zebrafish models | |
| P478 | volume | 307 | |